Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2026
Deep Learning-derived Sarcopenia Marker Predicts Benefit from Anti-EGFR Therapy in Patients with RAS Wild-Type Metastatic Colorectal CancerJulius Keyl, René Hosch, Fabian Hörst, et al.Eclinicalmedicine|January 13, 2025
Panitumumab plus 5-fluorouracil and folinic acid or 5-fluorouracil and folinic acid alone as maintenance therapy in RAS wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212): final efficacy analysis of a randomised, open-label, phase 2 trialArndt Stahler, Meinolf Karthaus, Stefan Fruehauf, et al.European Journal of Cancer (Oxford, England : 1990)|November 18, 2022
Depth of response of induction therapy and consecutive maintenance treatment in patients with RAS wild-type metastatic colorectal cancer: An analysis of the PanaMa trial (AIO KRK 0212)Greta Sommerhäuser, Annika Kurreck, Alexander Beck, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2025
Individual Patient Data Meta-Analysis of Consensus Molecular Subtypes as Biomarkers of First-Line Treatment in RAS Wild-Type Metastatic Colorectal CancerArndt Stahler, Dominik Paul Modest, Sebastian Stintzing, et al.European Journal of Cancer (Oxford, England : 1990)|July 16, 2023
Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy: a prespecified secondary analysis of the PanaMa (AIO KRK 0212) trialAlexej Ballhausen, Meinolf Karthaus, Stefan Fruehauf, et al.International Journal of Cancer|October 16, 2023
Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic colorectal cancer: Subgroup analysis of patients treated within the PanaMa trial (AIO KRK 0212)Greta Sommerhäuser, Meinolf Karthaus, Annika Kurreck, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2023
Consensus Molecular Subtypes as Biomarkers of Fluorouracil and Folinic Acid Maintenance Therapy With or Without Panitumumab in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa, AIO KRK 0212)Arndt Stahler, Beeke Hoppe, Il-Kang Na, et al.The Lancet. Oncology|May 24, 2014
Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trialDavid Malka, Pascale Cervera, Stéphanie Foulon, et al.Pageof 5